SCHEMBL2011090

SCHEMBL2011090

CN(C(=O)c1ccc2occ(Br)c2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.63
HCRTR2 O43614 2/20 0.63
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
HRH3 Q9Y5N1 5/20 0.39
HDAC6 Q9UBN7 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015342 1.00 HCRTR1 (0.63) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2011116 0.91 HCRTR1 (0.64) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2015169 0.85 HCRTR1 (0.65) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2010838 0.84 HCRTR1 (0.63) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2014119 0.83 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1HDAC6
SCHEMBL2010859 0.83 HCRTR1 (0.66) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2010631 0.83 HCRTR1 (0.65) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL13139060 0.83 HCRTR1 (0.77) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2013109 0.82 HCRTR1 (0.64) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2014534 0.82 HCRTR1 (0.66) HCRTR1HCRTR2RAB9ANPC1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed